Teladoc Health Inc (NYSE:TDOC) has been assigned an average recommendation of “Buy” from the twenty-three brokerages that are currently covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has issued a strong buy rating on the company. The average 1 year price target among brokers that have issued a report on the stock in the last year is $85.11.

A number of equities analysts have issued reports on TDOC shares. Svb Leerink reiterated an “outperform” rating on shares of Teladoc Health in a research report on Thursday, August 1st. Jefferies Financial Group reaffirmed a “buy” rating and issued a $95.00 price target on shares of Teladoc Health in a report on Tuesday, July 2nd. ValuEngine raised Teladoc Health from a “buy” rating to a “strong-buy” rating in a report on Thursday, June 27th. Zacks Investment Research raised Teladoc Health from a “sell” rating to a “hold” rating in a research note on Friday, May 3rd. Finally, SunTrust Banks raised their price target on Teladoc Health to $80.00 and gave the stock a “positive” rating in a research report on Tuesday, August 6th.

NYSE:TDOC traded down $4.68 during mid-day trading on Wednesday, hitting $61.24. 1,239,382 shares of the company’s stock traded hands, compared to its average volume of 1,361,599. The stock has a fifty day moving average of $67.84. Teladoc Health has a twelve month low of $42.08 and a twelve month high of $89.05. The company has a market cap of $4.67 billion, a P/E ratio of -42.53 and a beta of 1.30. The company has a quick ratio of 7.56, a current ratio of 7.56 and a debt-to-equity ratio of 0.43.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, July 31st. The health services provider reported ($0.41) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.40) by ($0.01). Teladoc Health had a negative net margin of 21.85% and a negative return on equity of 10.64%. The business had revenue of $130.30 million for the quarter, compared to analyst estimates of $129.54 million. During the same period in the prior year, the company earned ($0.40) earnings per share. The company’s quarterly revenue was up 37.8% on a year-over-year basis. Analysts expect that Teladoc Health will post -1.56 earnings per share for the current year.

In other news, insider Lewis Levy sold 2,025 shares of Teladoc Health stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $69.35, for a total transaction of $140,433.75. Following the sale, the insider now owns 5,655 shares in the company, valued at $392,174.25. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Andrew Turitz sold 9,157 shares of Teladoc Health stock in a transaction dated Monday, June 17th. The stock was sold at an average price of $60.05, for a total value of $549,877.85. Following the sale, the senior vice president now owns 6,826 shares in the company, valued at approximately $409,901.30. The disclosure for this sale can be found here. Insiders have sold a total of 151,763 shares of company stock valued at $9,981,248 over the last ninety days. 3.14% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently bought and sold shares of the company. Janus Henderson Group PLC increased its position in Teladoc Health by 87.2% in the 1st quarter. Janus Henderson Group PLC now owns 2,989,090 shares of the health services provider’s stock valued at $166,197,000 after acquiring an additional 1,391,969 shares during the period. Norges Bank acquired a new position in Teladoc Health in the 4th quarter valued at about $32,112,000. Nikko Asset Management Americas Inc. increased its position in Teladoc Health by 324.5% in the 2nd quarter. Nikko Asset Management Americas Inc. now owns 721,771 shares of the health services provider’s stock valued at $47,933,000 after acquiring an additional 551,755 shares during the period. Jennison Associates LLC increased its position in Teladoc Health by 60.6% in the 2nd quarter. Jennison Associates LLC now owns 1,172,135 shares of the health services provider’s stock valued at $77,841,000 after acquiring an additional 442,140 shares during the period. Finally, State of New Jersey Common Pension Fund D increased its position in Teladoc Health by 744.4% in the 1st quarter. State of New Jersey Common Pension Fund D now owns 380,000 shares of the health services provider’s stock valued at $21,128,000 after acquiring an additional 335,000 shares during the period.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Read More: Percentage Gainers

Analyst Recommendations for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.